⌘K

Login Start Free

Home/Filings/4/0001689375-24-000032

4//SEC Filing

KIM PETER S 4

Accession 0001689375-24-000032

CIK 0001689375other

View on SEC.gov Company Profile

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 4:31 PM ET

Size

6.7 KB

Accession

0001689375-24-000032

Insider Transaction Report

Form 4

Period: 2024-06-03

Entrada Therapeutics, Inc.TRDA

Director

Transactions

Exercise/Conversion
Common Stock
2024-06-03$6.06/sh+11,918$72,223→ 104,330 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-06-03−11,918→ 0 total
Exercise: $6.06Exp: 2032-06-02→ Common Stock (11,918 underlying)

Footnotes (1)

[F1]The shares subject to this option fully vested on June 2, 2023.

Documents

1 file

4
wk-form4_1717619480.xmlPrimary
FORM 4

Issuer

Entrada Therapeutics, Inc.

CIK 0001689375

Entity typeother

Related Parties

1

filerCIK 0001181180

Filing Metadata

Form type: 4
Filed: Jun 4, 8:00 PM ET
Accepted: Jun 5, 4:31 PM ET
Size: 6.7 KB

View on SEC.gov